Author

Kazuhiro Nagao

Observed names: K Nagao, K. NAGAO, K. Nagao, KAZUHIRO NAGAO, Kazuhiro NAGAO, Nagao, Kazuhiro

Observed institutions: Yamaguchi University, Wakayama Medical University, Hokkaido University, Radboud University Medical Center, Yamaguchi University Hospital, Yamaguchi Red Cross Hospital, Shuto General Hospital, Ube (Japan), Kindai University

ORCID: 0000-0001-8848-5804

Observed ORCID: 0000-0001-8848-5804

OpenAlex ID: A5050928355

Prognosis of Japanese Metastatic Renal Cell Carcinoma Patients in the Cytokine Era: A Cooperative Group Report of 1463 Patients

2009 · Sei Naito, Naoki Yamamoto, et al. · European Urology · 190

Oral 5‐aminolevulinic acid‐mediated photodynamic diagnosis using fluorescence cystoscopy for non‐muscle‐invasive bladder cancer: A multicenter phase III study

2018 · Yasushi Nakai, Keiji Inoue, et al. · International Journal of Urology · 107

PDF

Overexpression of Polo-Like Kinase 1 (PLK1) and Chromosomal Instability in Bladder Cancer

2006 · Yoshiaki Yamamoto, Hideyasu Matsuyama, et al. · Oncology · 88

Nucleotide Excision Repair Gene Polymorphisms May Predict Acute Toxicity in Patients Treated with Chemoradiotherapy for Bladder Cancer

2010 · Shigeru Sakano, Yuji Hinoda, et al. · Pharmacogenomics · 58

Clinical significance of CD44 variant 9 expression as a prognostic indicator in bladder cancer

2016 · Keita Kobayashi, Hiroaki Matsumoto, et al. · Oncology Reports · 50

PDF

Prognostic value of pre-treatment risk stratification and post-treatment neutrophil/lymphocyte ratio change for pembrolizumab in patients with advanced urothelial carcinoma

2020 · Yoshiaki Yamamoto, Junji Yatsuda, et al. · International Journal of Clinical Oncology · 44

Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma

2018 · Kazuhiro Nagao, Nachi Shinohara, et al. · BMC Cancer · 35

PDF

Risk of concomitant carcinoma in situ determining biopsy candidates among primary non‐muscle‐invasive bladder cancer patients: Retrospective analysis of 173 Japanese cases

2009 · Tomohiko Hara, Mutsuo Takahashi, et al. · International Journal of Urology · 33

The allelic loss of chromosome 3p25 with c‐myc gain is related to the development of clear‐cell renal cell carcinoma

2003 · S Yamaguchi, S Yoshihiro, et al. · Clinical Genetics · 27

Allelic loss of 3p25 associated with alterations of 5q22.3∼q23.2 may affect the prognosis of conventional renal cell carcinoma

2005 · Kazuhiro Nagao, Shiro Yamaguchi, et al. · Cancer Genetics and Cytogenetics · 26

Outcomes of subsequent non‐muscle‐invasive bladder cancer treated with intravesical Bacillus Calmette‐Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma

2017 · Makito Miyake, Yoshihiro Tatsumi, et al. · British Journal of Urology · 25

Ki67 and BUBR1 May Discriminate Clinically Insignificant Prostate Cancer in the PSA Range <4 ng/ml

2011 · K. Nagao, Y. Yamamoto, et al. · Japanese Journal of Clinical Oncology · 25

Association of TP53 and MDM2 polymorphisms with survival in bladder cancer patients treated with chemoradiotherapy

2009 · Asano Shinohara, Shigeru Sakano, et al. · Cancer Science · 25

Changes in oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma treated in the last two decades: a retrospective analysis based on a multicenter collaborative study

2016 · Makito Miyake, Yoshihiro Tatsumi, et al. · Japanese Journal of Clinical Oncology · 23

The systemic inflammation-based Glasgow Prognostic Score as a powerful prognostic factor in patients with upper tract urothelial carcinoma

2017 · Teruo Inamoto, Hideyasu Matsuyama, et al. · Oncotarget · 22

PDF

The Efficacy of Trimodal Chemoradiotherapy with Cisplatin as a Bladder-Preserving Strategy for the Treatment of Muscle-Invasive Bladder Cancer

2017 · Kazuhiro Nagao, Takahiko Hara, et al. · Urologia Internationalis · 22

Cytogenetic Analysis of False-Positive Mucosa by Photodynamic Diagnosis Using 5-Aminolevulinic Acid – Possible Existence of Premalignant Genomic Alterations Examined by in vitro Experiment

2009 · Hideyasu Matsuyama, Yoshiaki Yamamoto, et al. · Oncology · 22

Retroperitoneal Hematoma Due to Rupture of a Pseudoaneurysm Caused by Acupuncture Therapy

1998 · HIDEYASU MATSUYAMA, KAZUHIRO NAGAO, et al. · The Journal of Urology · 22

Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who had received prior cisplatin-based therapy

2006 · Nobuo Shinohara, Toru Harabayashi, et al. · Cancer Chemotherapy and Pharmacology · 21

Copy number aberrations using multicolour fluorescence in situ hybridization ( FISH ) for prognostication in non‐muscle‐invasive bladder cancer ( NIMBC )

2013 · Hideyasu Matsuyama, Kenzo Ikemoto, et al. · British Journal of Urology · 20

Running suture versus interrupted suture for vesicourethral anastomosis in retropubic radical prostatectomy: A randomized study

2014 · Hideyasu Matsuyama, Hiroaki Matsumoto, et al. · International Journal of Urology · 18

Clinical significance of lymph node dissection in renal cell carcinoma

2005 · Hideyasu Matsuyama, Hiroshi Hirata, et al. · Scandinavian Journal of Urology and Nephrology · 17

Positive voided urine cytology predicts worse pathological findings of nephroureterectomy specimens in patients with upper tract urothelial carcinoma: does selective ureteral cytology have an additional efficacy?

2015 · Shigeru Sakano, Teruo Inamoto, et al. · Japanese Journal of Clinical Oncology · 16

The association of DNA repair gene polymorphisms with the development and progression of renal cell carcinoma

2007 · S. Sakano, Y. Hinoda, et al. · Annals of Oncology · 16

PDF

Plasma cell leukaemia of non‐producer type with missing light chain gene rearrangement

1988 · Nobuhiko Tominaga, Shuichi Katagiri, et al. · British Journal of Haematology · 16

Works count: 114

Citation count: 1,256

H-index: 20

I10-index: 40